Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-25-000149
Filing Date
2025-03-26
Accepted
2025-03-26 11:17:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2893
  Complete submission text file 0001949846-25-000149.txt   4552
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36694 | Film No.: 25770810
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ARTARA THERAPEUTICS, INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Zummo Jacqueline (Reporting) CIK: 0001798929 (see all company filings)

Type: 144